Detalles de la búsqueda
1.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet
; 397(10275): 671-681, 2021 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545094
2.
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Lancet
; 396(10255): 887-897, 2020 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896291
3.
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A.
Front Immunol
; 14: 1098302, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865543
4.
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Front Immunol
; 14: 1129245, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063833
5.
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Front Immunol
; 14: 1228461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37600800
6.
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis.
Front Microbiol
; 13: 960937, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36238585
7.
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection.
Viruses
; 14(11)2022 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366583
8.
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Front Immunol
; 13: 822159, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35281053
9.
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates.
Emerg Microbes Infect
; 11(1): 2229-2247, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031930
10.
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.
Lancet Reg Health Eur
; 11: 100241, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746910
11.
Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice.
Toxins (Basel)
; 11(8)2019 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394847
Resultados
1 -
11
de 11
1
Próxima >
>>